These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31776763)

  • 1. Sustained hypoglycemia with therapeutic use of repaglinide.
    Hantson P; El Balkhi S; Haufroid V; Laterre PF
    Acta Diabetol; 2020 Jun; 57(6):751-753. PubMed ID: 31776763
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Khamaisi M; Leitersdorf E
    Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
    Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
    Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study.
    Wei Y; Lin FJ; Lin SY; Wang CC
    Clin Pharmacol Ther; 2019 Dec; 106(6):1346-1352. PubMed ID: 31216051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.
    Komatsu H; Enomoto M; Shiraishi H; Morita Y; Hashimoto D; Nakayama S; Funakoshi S; Hirano S; Terada Y; Miyamura M; Fujimoto S
    Diabetol Int; 2020 Oct; 11(4):388-392. PubMed ID: 33088647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged hypoglycemia after a suicidal ingestion of repaglinide with unexpected slow plasma elimination.
    Elling R; Spehl MS; Wohlfarth A; Auwaerter V; Hermanns-Clausen M
    Clin Toxicol (Phila); 2016; 54(2):158-60. PubMed ID: 26692235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hypoglycemia associated with repaglinide combined with clopidogrel, a retrospective cohort study.
    Akagi Y; Iketaki A; Kimura H; Matsudaira Y; Yoshida T; Nishimura T; Kawano Y; Mano Y; Shigematsu E; Ujihara M
    J Pharm Health Care Sci; 2020; 6():5. PubMed ID: 32206324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
    Takayama K; Fujii K; Yamaguchi H; Miyoshi Y; Uehara Y; Nagata S; Obata Y; Kosugi M; Hazama Y; Yasuda T
    Intern Med; 2021; 60(6):905-910. PubMed ID: 33716254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia probably due to accidental intake of repaglinide.
    Lee IT; Sheu WH; Lin SY
    Chang Gung Med J; 2002 Nov; 25(11):783-6. PubMed ID: 12553369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious hypoglycemia associated with misuse of repaglinide.
    Flood TM
    Endocr Pract; 1999; 5(3):137-8. PubMed ID: 15251685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Repaglinide, potentially a therapeutic improvement for diabetes mellitus type 2].
    Rutten GE
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1547-50. PubMed ID: 11525087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual crosslinked pectin-alginate network as sustained release hydrophilic matrix for repaglinide.
    Awasthi R; Kulkarni GT; Ramana MV; de Jesus Andreoli Pinto T; Kikuchi IS; Molim Ghisleni DD; de Souza Braga M; De Bank P; Dua K
    Int J Biol Macromol; 2017 Apr; 97():721-732. PubMed ID: 28115226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus.
    Shapiro MS; Abrams Z; Lieberman N
    Isr Med Assoc J; 2005 Feb; 7(2):75-7. PubMed ID: 15729954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meglitinide (repaglinide) therapy in permanent neonatal diabetes mellitus: two case reports.
    Razzaghy-Azar M; Nourbakhsh M; Talea A; Mohammad Amoli M; Nourbakhsh M; Larijani B
    J Med Case Rep; 2021 Oct; 15(1):535. PubMed ID: 34696808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repaglinide and diabetes: new preparation. No better than glucose-lowering sulphonamides.
    Prescrire Int; 2001 Feb; 10(51):9-11. PubMed ID: 11503861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.
    Kalbag JB; Walter YH; Nedelman JR; McLeod JF
    Diabetes Care; 2001 Jan; 24(1):73-7. PubMed ID: 11194245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repaglinide-induced factitious hypoglycemia.
    Hirshberg B; Skarulis MC; Pucino F; Csako G; Brennan R; Gorden P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):475-7. PubMed ID: 11157993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoglycaemia with oral antidiabetic drugs: results from prescription-event monitoring cohorts of rosiglitazone, pioglitazone, nateglinide and repaglinide.
    Vlckova V; Cornelius V; Kasliwal R; Wilton L; Shakir SA
    Drug Saf; 2009; 32(5):409-18. PubMed ID: 19419235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT.
    Mori K; Emoto M; Numaguchi R; Yamazaki Y; Urata H; Motoyama K; Morioka T; Shoji T; Inaba M
    Acta Endocrinol (Buchar); 2017; 13(2):133-137. PubMed ID: 31149163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repaglinide--a new compound for the treatment of patients with type 2 diabetes.
    Wolffenbuttel BH
    Neth J Med; 1999 Nov; 55(5):229-34. PubMed ID: 10593133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.